Introduction
The clinical diagnosis of Creutzfeldt-Jakob disease is based on a history of rapidly progressive dementia, presence of myoclonic movements, and a characteristic electroencephalogram.' However, clinical features are not always clearcut, and diagnostic overlap with other forms of dementia, including Alzheimer's disease, remains a problem in many cases.2 Some patients have atypical dementing illnesses which defy clinical categorisation; post mortem examination is necessary to achieve correct diagnosis in all cases of atypical dementia and suspected Creutzfeldt-Jakob disease. Most patients with classic Creutzfeldt-Jakob disease display at least some spongiform change in brain tissue.' This well recognised neuropathological feature is strongly supportive of a diagnosis of Creutzfeldt-Jakob disease, but is not pathognomonic because it is also found occasionally in cases of diffuse Lewy body disease and even in Alzheimer's disease. 4 However, other histological features, such as neurofibrillary tangles, senile plaques, and Lewy bodies assist in clarifying the final diagnosis. Creutzfeldt-Jakob disease can be transmitted to animals or man following inoculation or transplantation of infected tissue. 5 Research has shown that Creutzfeldt-Jakob disease and the related Gerstmann-Straussler syndrome are characterised by the presence of prion protein (PrP) which constitutes a significant part, if not the whole, of the infective agent.8 Recent progress in molecular biology has identified abnormalities in the PrP gene in some cases of familial Creutzfeldt-Jakob disease and in other cases of familial dementia with no characteristic pathology.9 These findings represent a challenge to the current classification of dementia and require urgent investigation. This places a very high priority on performing necropsy in cases suspected of having Creutzfeldt-Jakob disease.
Creutzfeldt-Jakob disease resembles spongiform encephalopathy in animals and the epidemic of bovine spongiform encephalopathy (BSE) has led to anxiety that the incidence of Creutzfeldt-Jakob disease will rise.'0 Because of this concern, the Department of Health has funded the setting up of a nationwide surveillance project to monitor the incidence of Creutzfeldt-Jakob disease, and this study is based in Edinburgh." The clinical surveillance is supervised by Dr R Will to whom all patients with a likely diagnosis of Creutzfeldt-Jakob disease should be notified. A very important part of the study is to obtain the brain for histological examination in as high a proportion of CreutzfeldtJakob disease cases as possible. Although guidelines for Creutzfeldt-Jakob disease necropsies have been published before,'2-14 the safety protocols contained therein need to be updated in the light of current knowledge. The Creutzfeldt-Jakob disease agent is a category 2 pathogen which presents special hazards in that it survives formalin fixation.
Some Creutzfeldt-Jakob disease cases are cared for in neurology units, and a neuropathologist with access to a specialised "high risk" mortuary may be asked to do the necropsy. In these circumstances, provided with dedicated instruments, autoclavable power saw, and full protective clothing, an extended necropsy, including removal of the spinal cord, can be undertaken. However, some cases occur in hospitals with no ready access to such facilities, and in these cases a more limited necropsy has to be performed. This Keeping the bag clear of the blade when it is switched on, the skull cap is drilled in the usual way. All the bone dust collects at the base of the bag. When this stage has been completed, the necropsy saw is removed through the hole at the top of the bag and this hole is resealed. The necropsy saw is laid down on the absorbent pad (as are all other instruments before and after use).
With the polythene bag still in place over the head, the skull cap is removed using Tchisel, mallet, and dura stripper introduced through small incisions on the superior surface of the bag (figs 4 and 5). The skull cap falls to the bottom of the bag.
The polythene bag may now be removed, handling with care because it contains bone dust and blood (fig 5) . The skull cap is retained on the absorbent pad ( fig 6) .
The dura is incised and reflected from the surface of the brain. At this stage, a specimen of cerebrospinal fluid may be aspirated from the third ventricle and tissue for freezing removed from the frontal lobes and from the cerebellum. These should be placed directly in universal containers labelled with warning of hazard and with patient identification. The brain is subsequently removed in the usual way ( fig 6) and placed directly into a preweighed container of 10% formalin which is similarly labelled (fig 7) . The container is handled by a clean assistant who brings it to the necropsy table. The container is sealed and weighed again to determine brain weight. Finally, the pituitary gland is removed and fixed in formalin. Phenol should not be added to the formalin as it has been shown to be ineffective in decontamination. '5 The body is reconstituted in the usual way by packing the skull cap with cotton wool and replacing it before the scalp is sutured.
If desired, the body cavities may be opened and the organs examined as usual, with tissue sampling for histology. Care The fixed brain can be stored safely in 10% formalin, in a box and an outer polythene bag, pending histological study. Samples for freezing should be double bagged and stored at -70°C. Notification of the necropsy to the Edinburgh Creutzfeldt-Jakob disease Surveillance Unit (see below) will be followed by collection of the specimens and, in due course, return of a full pathology report.
Any tissue blocks from non-central nervous system tissues may be decontaminated for routine microtomy by immersion for 1 hour in 96% formic acid, after formalin fixation and before processing. '7 Discussion This method of containment for removal of infective necropsy brain tissue within a polythene bag has been recommended in the past for AIDS cases'8 where specialist pathology suites were not available. It is equally suitable for cases of suspected Creutzfeldt-Jakob disease and is quite straightforward to undertake. It is hoped that use of this method would help to alleviate anxiety among pathology staff when confronted with cases of Creutzfeldt-Jakob disease and would allow the necropsy examination to proceed. Although spread of this disease is not thought to occur through contact with blood or bone, and the main risk remains inoculation,'6 it is clearly wise to limit contamination of staff and mortuary, which is why we recommend use of a polythene bag during skull removal. The relative risk of potential infectivity is lower in non central nervous system tissues apart perhaps from spleen and lymphoid tissue,"9 and examination of the whole body may be thought desirable at necropsy, to establish the cause of death.
Creutzfeldt-Jakob disease is a rare disorder; previous epidemiological studies have suggested an incidence of around 05-1/million population worldwide. Although a few cases of Creutzfeldt-Jakob disease have been reported in laboratory technical staff,20 and very recently in a pathologist,2' epidemiological studies have repeatedly failed to demonstrate an excess incidence of Creutzfeldt-Jakob disease in health care workers and post mortem room staff. In the United Kingdom the theoretical risk of transmission of the BSE agent to humans via the foodchain might result in an illness similar to Creutzfeldt-Jakob disease, hence the need for a longterm national prospective survey of human spongiform encephalopathies. The need for necropsy examination of (at least) the brain in suspected cases is of paramount importance for diagnostic verification and research, particularly in relation to cell pathology, molecular biology, and transmissibility. We hope that the work of the National Creutzfeldt-Jakob disease Surveillance Unit will continue to be supported by histopathologists, neuropathologists, and their mortuary and laboratory technical staff throughout the United Kingdom, on whose cooperation this project depends. Without this sort of help the study will not be successful and any possible hazards of BSE to human health will remain undetected.
The need for histological studies in suspected cases of Creutzfeldt-Jakob disease may pose further difficulties in relation to tissue handling in routine laboratories. The agent is classified as a category 2 pathogen, for which appropriate containment facilities are required. Furthermore, special precautions are required in relation to tissue sectioning, the disposal of contaminated laboratory fluids, and decontamination of equipment and work surfaces. These restrictions make it impracti- Figure 8 Additional hand protection is afforded by the use ofchain mail gloves worn between two pairs of rubber gloves. These protect against cuts and grazes but not -needlestick injuries. We are grateful to colleagues from all over the United Kingdom who have gone to a great deal of trouble to notify us of cases, remove brains, or arrange for cases to be moved to the nearest suitable necropsy facility. We thank Mr L Brett for expert photography and Miss J Mackenzie for typing the manuscript.
